| 3.48 0.07 (2.05%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.19 | 1-year : | 4.89 |
| Resists | First : | 3.58 | Second : | 4.19 |
| Pivot price | 2.94  |
|||
| Supports | First : | 2.65 | Second : | 2.07 |
| MAs | MA(5) : | 3.37 |
MA(20) : | 2.79 |
| MA(100) : | 3.29  |
MA(250) : | 3.74 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 83.6 |
D(3) : | 86.4 |
| RSI | RSI(14): 65 |
|||
| 52-week | High : | 7.61 | Low : | 1.8 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ ABOS ] has closed below upper band by 16.9%. Bollinger Bands are 68.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 3.57 - 3.59 | 3.59 - 3.6 |
| Low: | 3.36 - 3.38 | 3.38 - 3.39 |
| Close: | 3.46 - 3.48 | 3.48 - 3.5 |
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Fri, 26 Jul 2024
Short Interest in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Expands By 67.6% - MarketBeat
Fri, 26 Jul 2024
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Update - Defense World
Wed, 17 Jul 2024
Susquehanna Fundamental Investments LLC Invests $253,000 in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) - Defense World
Fri, 21 Jun 2024
Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds? - Insider Monkey
Tue, 14 May 2024
Earnings call: Acumen Pharmaceuticals reports progress in ALTITUDE-AD study - Investing.com
Sun, 21 Apr 2024
Is Acumen Pharmaceuticals (NASDAQ:ABOS) Weighed On By Its Debt Load? - Simply Wall St
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 60 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 11.2 (%) |
| Held by Institutions | 77.9 (%) |
| Shares Short | 990 (K) |
| Shares Short P.Month | 708 (K) |
| EPS | -1.05 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.36 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -16.9 % |
| Return on Equity (ttm) | -25.4 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.1 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -51 (M) |
| Levered Free Cash Flow | -35 (M) |
| PE Ratio | -3.32 |
| PEG Ratio | 13.2 |
| Price to Book value | 0.79 |
| Price to Sales | 0 |
| Price to Cash Flow | -4.12 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|